RE:T-VecLastly, T-Vec was administered intratumorally via intrahepatic injection and cannot be administered intravenously, which then severely impairs T-Vec'a ability to affect tumor mass any distance away from the intratumoral injection site.
Consequently these findings will certainly affect those OV companies who are currently employing herpes virus to treat liver cancer via an intratumoral injection.